HEADER    CYTOKINE                                27-OCT-07   3B64              
TITLE     MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) FROM                     
TITLE    2 /LEISHMANIA MAJOR                                                    
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: MACROPHAGE MIGRATION INHIBITORY FACTOR-LIKE                
COMPND   3 PROTEIN;                                                             
COMPND   4 CHAIN: A;                                                            
COMPND   5 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: LEISHMANIA MAJOR;                               
SOURCE   3 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   4 EXPRESSION_SYSTEM_STRAIN: BL21;                                      
SOURCE   5 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;                              
SOURCE   6 EXPRESSION_SYSTEM_PLASMID: PCRT7/CT-TOPO                             
KEYWDS    CYTOKINE, LEISHMANIA, MACROPHAGE MIGRATION INHIBITORY                 
KEYWDS   2 FACTOR, MIF, LM1740MIF, LMMIF, UNKNOWN FUNCTION                      
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    S.ZIEROW,Y.CHO,E.LOLIS                                                
REVDAT   2   24-FEB-09 3B64    1       VERSN                                    
REVDAT   1   10-JUN-08 3B64    0                                                
JRNL        AUTH   D.KAMIR,S.ZIEROW,L.LENG,Y.CHO,Y.DIAZ,J.GRIFFITH,             
JRNL        AUTH 2 C.MCDONALD,M.MERK,R.A.MITCHELL,J.TRENT,Y.CHEN,               
JRNL        AUTH 3 Y.K.KWONG,H.XIONG,J.VERMEIRE,M.CAPPELLO,                     
JRNL        AUTH 4 D.MCMAHON-PRATT,J.WALKER,J.BERNHAGEN,E.LOLIS,                
JRNL        AUTH 5 R.BUCALA                                                     
JRNL        TITL   A LEISHMANIA ORTHOLOG OF MACROPHAGE MIGRATION                
JRNL        TITL 2 INHIBITORY FACTOR MODULATES HOST MACROPHAGE                  
JRNL        TITL 3 RESPONSES.                                                   
JRNL        REF    J.IMMUNOL.                    V. 180  8250 2008              
JRNL        REFN                   ISSN 0022-1767                               
JRNL        PMID   18523291                                                     
REMARK   1                                                                      
REMARK   2                                                                      
REMARK   2 RESOLUTION.    1.03 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : SHELXL-97                                            
REMARK   3   AUTHORS     : G.M.SHELDRICK                                        
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.03                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 10.00                          
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000                          
REMARK   3   COMPLETENESS FOR RANGE        (%) : 100.0                          
REMARK   3   CROSS-VALIDATION METHOD           : FREE R                         
REMARK   3   FREE R VALUE TEST SET SELECTION   : RANDOM                         
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT (NO CUTOFF).                         
REMARK   3   R VALUE   (WORKING + TEST SET, NO CUTOFF) : 0.139                  
REMARK   3   R VALUE          (WORKING SET, NO CUTOFF) : 0.133                  
REMARK   3   FREE R VALUE                  (NO CUTOFF) : 0.157                  
REMARK   3   FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.300                  
REMARK   3   FREE R VALUE TEST SET COUNT   (NO CUTOFF) : 2334                   
REMARK   3   TOTAL NUMBER OF REFLECTIONS   (NO CUTOFF) : 44388                  
REMARK   3                                                                      
REMARK   3  FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F).                     
REMARK   3   R VALUE   (WORKING + TEST SET, F>4SIG(F)) : 0.133                  
REMARK   3   R VALUE          (WORKING SET, F>4SIG(F)) : 0.127                  
REMARK   3   FREE R VALUE                  (F>4SIG(F)) : 0.152                  
REMARK   3   FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.200                  
REMARK   3   FREE R VALUE TEST SET COUNT   (F>4SIG(F)) : 2033                   
REMARK   3   TOTAL NUMBER OF REFLECTIONS   (F>4SIG(F)) : 38792                  
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS      : 880                                           
REMARK   3   NUCLEIC ACID ATOMS : 0                                             
REMARK   3   HETEROGEN ATOMS    : 0                                             
REMARK   3   SOLVENT ATOMS      : 124                                           
REMARK   3                                                                      
REMARK   3  MODEL REFINEMENT.                                                   
REMARK   3   OCCUPANCY SUM OF NON-HYDROGEN ATOMS      : 985.00                  
REMARK   3   OCCUPANCY SUM OF HYDROGEN ATOMS          : 0.00                    
REMARK   3   NUMBER OF DISCRETELY DISORDERED RESIDUES : 13                      
REMARK   3   NUMBER OF LEAST-SQUARES PARAMETERS       : 9061                    
REMARK   3   NUMBER OF RESTRAINTS                     : 11105                   
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM RESTRAINT TARGET VALUES.                        
REMARK   3   BOND LENGTHS                         (A) : 0.016                   
REMARK   3   ANGLE DISTANCES                      (A) : 0.030                   
REMARK   3   SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000                   
REMARK   3   DISTANCES FROM RESTRAINT PLANES      (A) : 0.027                   
REMARK   3   ZERO CHIRAL VOLUMES               (A**3) : 0.097                   
REMARK   3   NON-ZERO CHIRAL VOLUMES           (A**3) : 0.092                   
REMARK   3   ANTI-BUMPING DISTANCE RESTRAINTS     (A) : 0.034                   
REMARK   3   RIGID-BOND ADP COMPONENTS         (A**2) : 0.006                   
REMARK   3   SIMILAR ADP COMPONENTS            (A**2) : 0.032                   
REMARK   3   APPROXIMATELY ISOTROPIC ADPS      (A**2) : 0.093                   
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELING.                                              
REMARK   3   METHOD USED: NULL                                                  
REMARK   3                                                                      
REMARK   3  STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER                      
REMARK   3   SPECIAL CASE: NULL                                                 
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: ANISOTROPIC REFINEMENT REDUCED FREE       
REMARK   3  R (NO CUTOFF) BY ?                                                  
REMARK   4                                                                      
REMARK   4 3B64 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-NOV-07.                  
REMARK 100 THE RCSB ID CODE IS RCSB045125.                                      
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 16-OCT-06                          
REMARK 200  TEMPERATURE           (KELVIN) : 100                                
REMARK 200  PH                             : 7.5                                
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : NSLS                               
REMARK 200  BEAMLINE                       : X29A                               
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 0.95                               
REMARK 200  MONOCHROMATOR                  : NULL                               
REMARK 200  OPTICS                         : NULL                               
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : CCD                                
REMARK 200  DETECTOR MANUFACTURER          : ADSC QUANTUM 315                   
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : HKL-2000                           
REMARK 200  DATA SCALING SOFTWARE          : SCALA                              
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 46731                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 1.030                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 50.000                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : 0.000                              
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 95.5                               
REMARK 200  DATA REDUNDANCY                : 5.200                              
REMARK 200  R MERGE                    (I) : 0.05100                            
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 22.0000                            
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.03                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 1.07                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 71.6                               
REMARK 200  DATA REDUNDANCY IN SHELL       : 3.40                               
REMARK 200  R MERGE FOR SHELL          (I) : 0.22800                            
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : 6.800                              
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: AB INITIO                    
REMARK 200 SOFTWARE USED: SHELX                                                 
REMARK 200 STARTING MODEL: NULL                                                 
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 40.22                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.06                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES-NA, 20% (V/V) ISO-           
REMARK 280  PROPANO POLYETHYLENE GLYCOL 4000, PH 7.5, VAPOR DIFFUSION,          
REMARK 280  HANGING DROP, TEMPERATURE 293K                                      
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: H 3                              
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -Y,X-Y,Z                                                
REMARK 290       3555   -X+Y,-X,Z                                               
REMARK 290       4555   X+2/3,Y+1/3,Z+1/3                                       
REMARK 290       5555   -Y+2/3,X-Y+1/3,Z+1/3                                    
REMARK 290       6555   -X+Y+2/3,-X+1/3,Z+1/3                                   
REMARK 290       7555   X+1/3,Y+2/3,Z+2/3                                       
REMARK 290       8555   -Y+1/3,X-Y+2/3,Z+2/3                                    
REMARK 290       9555   -X+Y+1/3,-X+2/3,Z+2/3                                   
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -0.500000 -0.866025  0.000000        0.00000            
REMARK 290   SMTRY2   2  0.866025 -0.500000  0.000000        0.00000            
REMARK 290   SMTRY3   2  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   3 -0.500000  0.866025  0.000000        0.00000            
REMARK 290   SMTRY2   3 -0.866025 -0.500000  0.000000        0.00000            
REMARK 290   SMTRY3   3  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   4  1.000000  0.000000  0.000000       26.16050            
REMARK 290   SMTRY2   4  0.000000  1.000000  0.000000       15.10377            
REMARK 290   SMTRY3   4  0.000000  0.000000  1.000000       32.27233            
REMARK 290   SMTRY1   5 -0.500000 -0.866025  0.000000       26.16050            
REMARK 290   SMTRY2   5  0.866025 -0.500000  0.000000       15.10377            
REMARK 290   SMTRY3   5  0.000000  0.000000  1.000000       32.27233            
REMARK 290   SMTRY1   6 -0.500000  0.866025  0.000000       26.16050            
REMARK 290   SMTRY2   6 -0.866025 -0.500000  0.000000       15.10377            
REMARK 290   SMTRY3   6  0.000000  0.000000  1.000000       32.27233            
REMARK 290   SMTRY1   7  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   7  0.000000  1.000000  0.000000       30.20754            
REMARK 290   SMTRY3   7  0.000000  0.000000  1.000000       64.54467            
REMARK 290   SMTRY1   8 -0.500000 -0.866025  0.000000        0.00000            
REMARK 290   SMTRY2   8  0.866025 -0.500000  0.000000       30.20754            
REMARK 290   SMTRY3   8  0.000000  0.000000  1.000000       64.54467            
REMARK 290   SMTRY1   9 -0.500000  0.866025  0.000000        0.00000            
REMARK 290   SMTRY2   9 -0.866025 -0.500000  0.000000       30.20754            
REMARK 290   SMTRY3   9  0.000000  0.000000  1.000000       64.54467            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC                          
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC                   
REMARK 350 SOFTWARE USED: PISA                                                  
REMARK 350 TOTAL BURIED SURFACE AREA: 7410 ANGSTROM**2                          
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 350   BIOMT1   2 -0.500000 -0.866025  0.000000       26.16050            
REMARK 350   BIOMT2   2  0.866025 -0.500000  0.000000       45.31132            
REMARK 350   BIOMT3   2  0.000000  0.000000  1.000000        0.00000            
REMARK 350   BIOMT1   3 -0.500000  0.866025  0.000000      -26.16050            
REMARK 350   BIOMT2   3 -0.866025 -0.500000  0.000000       45.31132            
REMARK 350   BIOMT3   3  0.000000  0.000000  1.000000        0.00000            
REMARK 470                                                                      
REMARK 470 MISSING ATOM                                                         
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER;            
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;          
REMARK 470 I=INSERTION CODE):                                                   
REMARK 470   M RES CSSEQI  ATOMS                                                
REMARK 470     GLN A   4    CG   CD   OE1  NE2                                  
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES                                       
REMARK 500                                                                      
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES              
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE               
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                 
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)              
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999                        
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996                     
REMARK 500                                                                      
REMARK 500  M RES CSSEQI ATM1   ATM2   ATM3                                     
REMARK 500    ARG A  16   NE  -  CZ  -  NH1 ANGL. DEV. =  -4.2 DEGREES          
REMARK 500    ARG A  16   NE  -  CZ  -  NH2 ANGL. DEV. =   5.0 DEGREES          
REMARK 500    ARG A  28   NE  -  CZ  -  NH1 ANGL. DEV. =   4.3 DEGREES          
REMARK 500    ARG A  28   NE  -  CZ  -  NH2 ANGL. DEV. =  -3.0 DEGREES          
REMARK 500    PHE A  51   CB  -  CG  -  CD1 ANGL. DEV. =  -5.0 DEGREES          
REMARK 500    ARG A  61   CD  -  NE  -  CZ  ANGL. DEV. =  -9.5 DEGREES          
REMARK 500    ARG A  61   NH1 -  CZ  -  NH2 ANGL. DEV. =  -9.5 DEGREES          
REMARK 500    ARG A  61   NE  -  CZ  -  NH2 ANGL. DEV. =   8.6 DEGREES          
REMARK 500    GLU A  74   OE1 -  CD  -  OE2 ANGL. DEV. =  -7.2 DEGREES          
REMARK 500    ASP A  93   CB  -  CG  -  OD1 ANGL. DEV. =  -7.8 DEGREES          
REMARK 500    PHE A  96   CB  -  CG  -  CD2 ANGL. DEV. =   4.5 DEGREES          
REMARK 500    PHE A  96   CB  -  CG  -  CD1 ANGL. DEV. =  -4.6 DEGREES          
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPA A 113                 
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1MIF   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE AT 2.6-A RESOLUTION OF HUMAN MACROPHAGE            
REMARK 900 MIGRATION INHIBITORY FACTOR.                                         
REMARK 900 RELATED ID: 2OS5   RELATED DB: PDB                                   
REMARK 900 STRUCTURAL CHARACTERIZATION OF A MACROPHAGE MIGRATION                
REMARK 900 INHIBITORY FACTOR FROM ANCYLOSTOMA HOOKWORMS: EVIDENCE FOR           
REMARK 900 INTERACTION WITH HUMAN MIF RECEPTOR CD74                             
DBREF  3B64 A    1   112  UNP    Q4Q413   Q4Q413_LEIMA     2    113             
SEQRES   1 A  112  PRO VAL ILE GLN THR PHE VAL SER THR PRO LEU ASP HIS          
SEQRES   2 A  112  HIS LYS ARG GLU ASN LEU ALA GLN VAL TYR ARG ALA VAL          
SEQRES   3 A  112  THR ARG ASP VAL LEU GLY LYS PRO GLU ASP LEU VAL MET          
SEQRES   4 A  112  MET THR PHE HIS ASP SER THR PRO MET HIS PHE PHE GLY          
SEQRES   5 A  112  SER THR ASP PRO VAL ALA CYS VAL ARG VAL GLU ALA LEU          
SEQRES   6 A  112  GLY GLY TYR GLY PRO SER GLU PRO GLU LYS VAL THR SER          
SEQRES   7 A  112  ILE VAL THR ALA ALA ILE THR LYS GLU CYS GLY ILE VAL          
SEQRES   8 A  112  ALA ASP ARG ILE PHE VAL LEU TYR PHE SER PRO LEU HIS          
SEQRES   9 A  112  CYS GLY TRP ASN GLY THR ASN PHE                              
HET    IPA  A 113       4                                                       
HETNAM     IPA ISOPROPYL ALCOHOL                                                
HETSYN     IPA 2-PROPANOL                                                       
FORMUL   2  IPA    C3 H8 O                                                      
FORMUL   3  HOH   *120(H2 O)                                                    
HELIX    1   1 ASP A   12  VAL A   30  1                                  19    
HELIX    2   2 PRO A   34  VAL A   38  5                                   5    
HELIX    3   3 SER A   71  GLY A   89  1                                  19    
HELIX    4   4 VAL A   91  ASP A   93  5                                   3    
SHEET    1   A 4 MET A  39  HIS A  43  0                                        
SHEET    2   A 4 VAL A   2  VAL A   7  1  N  THR A   5   O  HIS A  43           
SHEET    3   A 4 ALA A  58  GLU A  63 -1  O  ARG A  61   N  GLN A   4           
SHEET    4   A 4 ILE A  95  PHE A 100  1  O  LEU A  98   N  VAL A  62           
SHEET    1   B 2 GLY A 106  TRP A 107  0                                        
SHEET    2   B 2 THR A 110  ASN A 111 -1  O  THR A 110   N  TRP A 107           
SITE     1 AC1  4 TRP A 107  THR A 110  ASN A 111  PHE A 112                    
CRYST1   52.321   52.321   96.817  90.00  90.00 120.00 H 3           9          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.019113  0.011035  0.000000        0.00000                         
SCALE2      0.000000  0.022070  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.010329        0.00000                         
ATOM      2  CA  PRO A   1     -12.821  29.162   8.630  1.00 12.58           C  
ANISOU    2  CA  PRO A   1     1558   2030   1190     49    -25     76       C  
ATOM      9  CA  VAL A   2     -10.304  29.171   5.772  1.00 10.26           C  
ANISOU    9  CA  VAL A   2     1516   1446    938     83   -103    -21       C  
ATOM     16  CA  ILE A   3      -9.290  25.972   3.929  1.00 10.05           C  
ANISOU   16  CA  ILE A   3     1501   1475    843    150   -162    -14       C  
ATOM     24  CA  GLN A   4      -6.397  26.244   1.478  1.00 10.30           C  
ANISOU   24  CA  GLN A   4     1490   1485    939     45    -85     50       C  
ATOM     29  CA  THR A   5      -5.906  23.206  -0.783  1.00  9.06           C  
ANISOU   29  CA  THR A   5     1313   1273    856     30   -106    124       C  
ATOM     36  CA  PHE A   6      -2.478  22.721  -2.401  1.00  9.63           C  
ANISOU   36  CA  PHE A   6     1268   1453    936     23    -70    -57       C  
ATOM     47  CA  VAL A   7      -2.202  19.790  -4.773  1.00 10.61           C  
ANISOU   47  CA  VAL A   7     1502   1445   1085    -96     -7    -83       C  
ATOM     54  CA  SER A   8       0.524  18.893  -7.259  1.00 11.22           C  
ANISOU   54  CA  SER A   8     1534   1723   1007      6    -59   -155       C  
ATOM     60  CA  THR A   9      -2.062  17.655  -9.800  1.00 13.08           C  
ANISOU   60  CA  THR A   9     1816   1900   1255     14   -331   -384       C  
ATOM     67  CA  PRO A  10      -4.369  19.736 -11.969  1.00 14.55           C  
ANISOU   67  CA  PRO A  10     1966   2258   1303   -266   -398     96       C  
ATOM     74  CA  LEU A  11      -7.805  20.548 -10.573  1.00 14.52           C  
ANISOU   74  CA  LEU A  11     1843   2117   1559   -115   -485    142       C  
ATOM     82  CA  ASP A  12     -10.819  21.082 -12.829  1.00 13.24           C  
ANISOU   82  CA  ASP A  12     1881   2082   1070   -372   -351     60       C  
ATOM     90  CA  HIS A  13     -14.195  22.559 -12.148  1.00 13.67           C  
ANISOU   90  CA  HIS A  13     2090   1827   1278   -141   -517     99       C  
ATOM    100  CA  HIS A  14     -15.684  19.252 -11.034  1.00 12.56           C  
ANISOU  100  CA  HIS A  14     1870   1918    987   -354   -313   -190       C  
ATOM    110  CA  LYS A  15     -12.993  18.555  -8.475  1.00 11.51           C  
ANISOU  110  CA  LYS A  15     1850   1593    932      8   -269   -165       C  
ATOM    124  CA  ARG A  16     -13.095  22.091  -7.091  1.00 11.40           C  
ANISOU  124  CA  ARG A  16     1681   1513   1139   -104   -343   -198       C  
ATOM    135  CA  GLU A  17     -16.862  22.016  -6.688  1.00 12.25           C  
ANISOU  135  CA  GLU A  17     1667   1728   1261    -77   -294    -91       C  
ATOM    144  CA  ASN A  18     -16.850  18.529  -5.115  1.00 11.60           C  
ANISOU  144  CA  ASN A  18     1471   1676   1260   -115   -235   -132       C  
ATOM    152  CA  LEU A  19     -14.139  19.508  -2.624  1.00 10.94           C  
ANISOU  152  CA  LEU A  19     1551   1510   1095    -92   -318    -87       C  
ATOM    160  CA  ALA A  20     -15.997  22.750  -1.835  1.00 11.69           C  
ANISOU  160  CA  ALA A  20     1775   1415   1251    -96   -125     38       C  
ATOM    165  CA  GLN A  21     -19.102  20.707  -0.977  1.00 12.22           C  
ANISOU  165  CA  GLN A  21     1518   1772   1351    -11   -282     21       C  
ATOM    174  CA  VAL A  22     -17.056  18.458   1.309  1.00 11.69           C  
ANISOU  174  CA  VAL A  22     1607   1560   1275    -88   -225     32       C  
ATOM    181  CA  TYR A  23     -15.485  21.456   3.041  1.00 10.44           C  
ANISOU  181  CA  TYR A  23     1319   1482   1166      3    -66     15       C  
ATOM    193  CA  ARG A  24     -18.870  23.149   3.491  1.00 10.99           C  
ANISOU  193  CA  ARG A  24     1323   1596   1256     69   -118     24       C  
ATOM    204  CA  ALA A  25     -20.267  19.974   5.029  1.00 13.26           C  
ANISOU  204  CA  ALA A  25     1612   1833   1593   -379   -227    198       C  
ATOM    209  CA  VAL A  26     -17.250  19.556   7.336  1.00 12.50           C  
ANISOU  209  CA  VAL A  26     1790   1709   1252    182    -75    142       C  
ATOM    218  CA  THR A  27     -17.578  23.169   8.474  1.00 11.27           C  
ANISOU  218  CA  THR A  27     1384   1698   1202   -153     89    110       C  
ATOM    225  CA  ARG A  28     -21.254  22.697   9.338  1.00 13.07           C  
ANISOU  225  CA  ARG A  28     1427   1922   1618    -80    197    306       C  
ATOM    236  CA  ASP A  29     -21.296  19.110  10.638  1.00 14.20           C  
ANISOU  236  CA  ASP A  29     1596   2039   1762    -79    158    493       C  
ATOM    244  CA  VAL A  30     -17.878  18.804  12.304  1.00 13.20           C  
ANISOU  244  CA  VAL A  30     1608   2011   1398    184    168    318       C  
ATOM    251  CA  LEU A  31     -16.795  22.319  13.160  1.00 13.53           C  
ANISOU  251  CA  LEU A  31     1853   1981   1305    177    -82     94       C  
ATOM    259  CA  GLY A  32     -20.346  23.502  13.999  1.00 15.22           C  
ANISOU  259  CA  GLY A  32     1937   2396   1449    299    250    159       C  
ATOM    263  CA  LYS A  33     -19.885  26.754  12.005  1.00 14.17           C  
ANISOU  263  CA  LYS A  33     1787   2060   1536    240    193    -10       C  
ATOM    272  CA  PRO A  34     -21.883  28.314   9.143  1.00 14.39           C  
ANISOU  272  CA  PRO A  34     1888   1808   1770    212    161    220       C  
ATOM    279  CA  GLU A  35     -21.013  26.572   5.868  1.00 13.94           C  
ANISOU  279  CA  GLU A  35     1791   1947   1558    119     99    277       C  
ATOM    288  CA  ASP A  36     -21.252  29.883   3.960  1.00 12.98           C  
ANISOU  288  CA  ASP A  36     1379   1928   1624     76    -91    359       C  
ATOM    296  CA  LEU A  37     -18.357  31.228   6.108  1.00 12.60           C  
ANISOU  296  CA  LEU A  37     1345   1925   1518     90    106     20       C  
ATOM    304  CA  VAL A  38     -15.659  28.763   5.054  1.00 10.39           C  
ANISOU  304  CA  VAL A  38     1326   1447   1175    -59    -23    149       C  
ATOM    311  CA  MET A  39     -13.455  30.536   2.489  1.00  9.93           C  
ANISOU  311  CA  MET A  39     1423   1311   1038     37    -76     71       C  
ATOM    319  CA  MET A  40     -11.736  28.072   0.230  1.00 10.47           C  
ANISOU  319  CA  MET A  40     1537   1353   1089    173   -197     37       C  
ATOM    327  CA  THR A  41      -8.741  28.543  -2.047  1.00 10.97           C  
ANISOU  327  CA  THR A  41     1529   1629   1011     53   -156    168       C  
ATOM    334  CA  PHE A  42      -7.442  26.015  -4.564  1.00 10.50           C  
ANISOU  334  CA  PHE A  42     1461   1577    950     29   -137    241       C  
ATOM    345  CA  HIS A  43      -3.827  25.895  -5.704  1.00 10.63           C  
ANISOU  345  CA  HIS A  43     1441   1567   1032    -52     99    116       C  
ATOM    355  CA  ASP A  44      -3.359  23.200  -8.349  1.00 11.20           C  
ANISOU  355  CA  ASP A  44     1543   1573   1141    -31   -143     25       C  
ATOM    363  CA  SER A  45      -0.370  21.972 -10.313  1.00 12.48           C  
ANISOU  363  CA  SER A  45     1579   2280    886   -230    -23   -174       C  
ATOM    371  CA  THR A  46       1.802  23.120  -7.415  1.00 10.94           C  
ANISOU  371  CA  THR A  46     1438   1766    954    -49    -64   -212       C  
ATOM    378  CA  PRO A  47       5.404  21.881  -7.784  1.00 10.95           C  
ANISOU  378  CA  PRO A  47     1450   1776    934   -162     63   -282       C  
ATOM    385  CA  MET A  48       5.870  19.799  -4.645  1.00 10.48           C  
ANISOU  385  CA  MET A  48     1384   1552   1047    -77      8   -232       C  
ATOM    393  CA  HIS A  49       8.354  17.365  -3.188  1.00 11.18           C  
ANISOU  393  CA  HIS A  49     1419   1682   1148     47     -4   -326       C  
ATOM    403  CA  PHE A  50       7.654  14.831  -0.446  1.00 10.79           C  
ANISOU  403  CA  PHE A  50     1359   1373   1368     55     76   -342       C  
ATOM    414  CA  PHE A  51       8.907  11.415   0.571  1.00 12.65           C  
ANISOU  414  CA  PHE A  51     1650   1432   1725    157    -43   -273       C  
ATOM    425  CA  GLY A  52      11.619  11.608  -2.158  1.00 14.47           C  
ANISOU  425  CA  GLY A  52     1604   2083   1810    522     70   -487       C  
ATOM    429  CA  SER A  53       9.443  12.415  -5.125  1.00 15.03           C  
ANISOU  429  CA  SER A  53     2084   1857   1770    314    -92   -633       C  
ATOM    435  CA  THR A  54       7.337  14.933  -6.965  1.00 13.85           C  
ANISOU  435  CA  THR A  54     1860   2071   1332     99    174   -300       C  
ATOM    442  CA  ASP A  55       4.505  12.419  -7.417  1.00 15.62           C  
ANISOU  442  CA  ASP A  55     1982   2086   1867    -30    353   -751       C  
ATOM    450  CA  PRO A  56       0.874  13.402  -6.667  1.00 12.78           C  
ANISOU  450  CA  PRO A  56     1795   1796   1265    -75      6   -446       C  
ATOM    457  CA  VAL A  57       0.733  14.970  -3.219  1.00 10.40           C  
ANISOU  457  CA  VAL A  57     1356   1464   1133    -46    -14   -290       C  
ATOM    464  CA  ALA A  58      -1.487  17.316  -1.253  1.00  9.47           C  
ANISOU  464  CA  ALA A  58     1300   1256   1041     -7      5   -135       C  
ATOM    469  CA  CYS A  59      -1.253  19.787   1.634  1.00  9.58           C  
ANISOU  469  CA  CYS A  59     1378   1338    925     82    -79   -116       C  
ATOM    475  CA  VAL A  60      -4.525  21.106   3.047  1.00 10.30           C  
ANISOU  475  CA  VAL A  60     1673   1372    868    301     59    107       C  
ATOM    482  CA  ARG A  61      -4.349  23.955   5.550  1.00 10.44           C  
ANISOU  482  CA  ARG A  61     1535   1474    957    108    -19     29       C  
ATOM    493  CA  VAL A  62      -7.280  24.578   7.869  1.00 10.19           C  
ANISOU  493  CA  VAL A  62     1436   1523    912    208   -102    -30       C  
ATOM    500  CA  GLU A  63      -7.559  27.861   9.806  1.00 11.22           C  
ANISOU  500  CA  GLU A  63     1720   1613    932    295   -137    -95       C  
ATOM    509  CA  ALA A  64     -10.312  28.494  12.353  1.00 11.41           C  
ANISOU  509  CA  ALA A  64     1656   1575   1106   -140     25   -106       C  
ATOM    514  CA  LEU A  65     -10.632  31.327  14.823  1.00 13.25           C  
ANISOU  514  CA  LEU A  65     2090   1739   1206    220    171   -244       C  
ATOM    522  CA  GLY A  66     -11.088  29.792  18.294  1.00 18.61           C  
ANISOU  522  CA  GLY A  66     3714   2107   1252   -340    835   -277       C  
ATOM    526  CA  GLY A  67      -9.381  26.495  17.374  1.00 15.50           C  
ANISOU  526  CA  GLY A  67     2477   1821   1592   -391    -15     71       C  
ATOM    530  CA  TYR A  68     -11.021  23.093  17.427  1.00 12.85           C  
ANISOU  530  CA  TYR A  68     2029   1722   1132   -157    112    218       C  
ATOM    542  CA  GLY A  69     -13.099  20.885  19.716  1.00 13.76           C  
ANISOU  542  CA  GLY A  69     2024   2011   1192      3    284    390       C  
ATOM    546  CA  PRO A  70     -11.421  17.726  21.065  1.00 14.41           C  
ANISOU  546  CA  PRO A  70     2042   2361   1073    -36    -93    725       C  
ATOM    553  CA  SER A  71     -12.589  15.247  18.412  1.00 15.31           C  
ANISOU  553  CA  SER A  71     2120   2065   1633   -290   -204    729       C  
ATOM    559  CA  GLU A  72     -12.842  17.661  15.486  1.00 11.90           C  
ANISOU  559  CA  GLU A  72     1621   1830   1072    147    -14    192       C  
ATOM    568  CA  PRO A  73      -9.296  17.504  13.979  1.00 12.35           C  
ANISOU  568  CA  PRO A  73     1521   1815   1355     18     73    236       C  
ATOM    575  CA  GLU A  74      -9.378  13.679  13.842  1.00 14.00           C  
ANISOU  575  CA  GLU A  74     1892   1837   1591    377    -41    140       C  
ATOM    584  CA  LYS A  75     -12.698  13.802  12.019  1.00 12.96           C  
ANISOU  584  CA  LYS A  75     1591   1702   1633   -156    137    276       C  
ATOM    593  CA  VAL A  76     -11.638  16.595   9.616  1.00 11.24           C  
ANISOU  593  CA  VAL A  76     1345   1559   1365    -96     95    170       C  
ATOM    600  CA  THR A  77      -8.391  14.746   8.787  1.00 11.17           C  
ANISOU  600  CA  THR A  77     1497   1448   1301    -30    117     55       C  
ATOM    607  CA  SER A  78     -10.286  11.557   8.011  1.00 11.96           C  
ANISOU  607  CA  SER A  78     1543   1483   1520   -132     42    184       C  
ATOM    615  CA  ILE A  79     -12.889  13.291   5.845  1.00 12.17           C  
ANISOU  615  CA  ILE A  79     1552   1680   1393     -1    117    157       C  
ATOM    623  CA  VAL A  80     -10.514  15.593   3.995  1.00 11.40           C  
ANISOU  623  CA  VAL A  80     1598   1462   1273    -94     60     69       C  
ATOM    630  CA  THR A  81      -7.970  12.825   3.325  1.00 11.27           C  
ANISOU  630  CA  THR A  81     1487   1541   1256    -84    -11    -68       C  
ATOM    637  CA  ALA A  82     -10.673  10.532   1.912  1.00 12.18           C  
ANISOU  637  CA  ALA A  82     1623   1549   1455   -302      8    124       C  
ATOM    642  CA  ALA A  83     -12.075  13.376  -0.226  1.00 11.86           C  
ANISOU  642  CA  ALA A  83     1500   1478   1528   -120     21    135       C  
ATOM    647  CA  ILE A  84      -8.690  14.319  -1.702  1.00 11.01           C  
ANISOU  647  CA  ILE A  84     1475   1491   1219    -90    -62     14       C  
ATOM    655  CA  THR A  85      -8.035  10.665  -2.556  1.00 11.83           C  
ANISOU  655  CA  THR A  85     1626   1354   1514   -260    -33    -46       C  
ATOM    662  CA  LYS A  86     -11.524  10.360  -4.079  1.00 13.36           C  
ANISOU  662  CA  LYS A  86     1655   1880   1540   -471    -79    -78       C  
ATOM    671  CA  GLU A  87     -11.370  13.578  -6.126  1.00 12.84           C  
ANISOU  671  CA  GLU A  87     1625   1777   1475    -56   -141    -87       C  
ATOM    680  CA  CYS A  88      -7.685  13.755  -7.038  1.00 11.87           C  
ANISOU  680  CA  CYS A  88     1592   1613   1307   -213    -48   -191       C  
ATOM    686  CA  GLY A  89      -6.442  10.171  -6.786  1.00 12.24           C  
ANISOU  686  CA  GLY A  89     1677   1600   1375    -89   -190   -241       C  
ATOM    690  CA  ILE A  90      -3.706  11.200  -4.351  1.00 11.55           C  
ANISOU  690  CA  ILE A  90     1726   1449   1214    -91   -144   -193       C  
ATOM    698  CA  VAL A  91      -2.909   8.431  -1.923  1.00 13.35           C  
ANISOU  698  CA  VAL A  91     1945   1411   1715    -12   -225   -130       C  
ATOM    705  CA  ALA A  92      -3.441   8.939   1.825  1.00 13.17           C  
ANISOU  705  CA  ALA A  92     1799   1480   1726   -122    -48    258       C  
ATOM    710  CA  ASP A  93       0.251   8.685   2.670  1.00 12.90           C  
ANISOU  710  CA  ASP A  93     1679   1324   1898     92    -96     84       C  
ATOM    718  CA  ARG A  94       0.870  11.648   0.365  1.00 11.14           C  
ANISOU  718  CA  ARG A  94     1604   1231   1399     -5    105    -79       C  
ATOM    729  CA  ILE A  95      -1.744  13.921   2.098  1.00  9.91           C  
ANISOU  729  CA  ILE A  95     1451   1189   1124      3    -21    -16       C  
ATOM    737  CA  PHE A  96      -1.000  16.328   4.944  1.00  9.62           C  
ANISOU  737  CA  PHE A  96     1383   1233   1040     49   -119    -88       C  
ATOM    748  CA  VAL A  97      -3.718  18.260   6.741  1.00  9.69           C  
ANISOU  748  CA  VAL A  97     1501   1325    858     33     61     34       C  
ATOM    755  CA  LEU A  98      -2.438  21.110   8.943  1.00  9.81           C  
ANISOU  755  CA  LEU A  98     1445   1422    862     30    -14     49       C  
ATOM    763  CA  TYR A  99      -4.483  23.021  11.512  1.00  9.67           C  
ANISOU  763  CA  TYR A  99     1349   1362    964     98    -11     37       C  
ATOM    775  CA  PHE A 100      -4.026  26.581  12.677  1.00 11.24           C  
ANISOU  775  CA  PHE A 100     1779   1327   1166     83   -372    -13       C  
ATOM    786  CA  SER A 101      -5.933  29.244  14.510  1.00 13.92           C  
ANISOU  786  CA  SER A 101     2043   1407   1840     58   -173   -348       C  
ATOM    794  CA  PRO A 102      -5.552  32.924  13.624  1.00 12.22           C  
ANISOU  794  CA  PRO A 102     2064   1491   1089    -69    145   -147       C  
ATOM    801  CA  LEU A 103      -5.394  35.459  16.431  1.00 10.92           C  
ANISOU  801  CA  LEU A 103     1677   1453   1018      8     67    -91       C  
ATOM    809  CA  HIS A 104      -7.968  37.623  14.729  1.00 11.19           C  
ANISOU  809  CA  HIS A 104     1565   1725    962    110    264    107       C  
ATOM    819  CA  CYS A 105     -10.228  37.450  11.680  1.00 12.46           C  
ANISOU  819  CA  CYS A 105     1709   2010   1016    382    204     25       C  
ATOM    825  CA  GLY A 106     -12.004  40.238   9.855  1.00 12.07           C  
ANISOU  825  CA  GLY A 106     1605   1955   1027    428     17   -150       C  
ATOM    829  CA  TRP A 107     -15.069  39.828   7.599  1.00 11.15           C  
ANISOU  829  CA  TRP A 107     1341   1664   1231    207     66     25       C  
ATOM    843  CA  ASN A 108     -17.244  42.570   6.124  1.00 12.85           C  
ANISOU  843  CA  ASN A 108     1491   1761   1632    203    -20    120       C  
ATOM    851  CA  GLY A 109     -14.813  45.140   7.561  1.00 13.47           C  
ANISOU  851  CA  GLY A 109     1991   1562   1566    151   -118    141       C  
ATOM    855  CA  THR A 110     -15.049  44.082  11.227  1.00 15.58           C  
ANISOU  855  CA  THR A 110     2374   2046   1498    815    366    -55       C  
ATOM    862  CA  ASN A 111     -13.301  41.493  13.384  1.00 12.37           C  
ANISOU  862  CA  ASN A 111     1384   1896   1420    113    164    102       C  
ATOM    870  CA  PHE A 112     -15.066  38.541  15.016  1.00 13.19           C  
ANISOU  870  CA  PHE A 112     1674   1942   1397    265    352    324       C  
TER     881      PHE A 112                                                      
CONECT  882  883                                                                
CONECT  883  882  884  885                                                      
CONECT  884  883                                                                
CONECT  885  883                                                                
MASTER      258    0    1    4    6    0    1    6 1004    1    4    9          
END                                                                             
